PHQ-9 Depression Test Questionnaire
OS :
Version :1.0.1
Size :31.90Mb
Updated :Mar 11,2016
Developer :Andrey Fetisov
Ask AI
You can ask the AI some questions about the app
Based on the PHQ-9 Depression Test, here are three topics that users often discuss online: 1. How accurate is the PHQ-9 test for diagnosing depression? 2. What are the limitations of using a self-assessment test for depression? 3. How can the PHQ-9 app be used in combination with professional therapy and treatment?
Q{{(index+1)}}{{item}}Ask AI
Pros and Cons from users' feedback
Based on the user reviews of the PHQ-9 Depression Test Questionnaire app, here are three pros and three cons in 15 words or less each: Pros: 1. Accurate diagnosis: Users praised the app for providing accurate depression diagnosis and scoring. 2. Easy to use: Reviewers found the app user-friendly and simple to navigate, making it accessible to many. 3. Convenient: Users appreciated the app's ability to provide instant feedback and scoring, making it a convenient tool. Cons: 1. Limited support: Some users reported difficulty accessing customer support or feeling like their concerns were not heard. 2. Technical issues: A few reviewers experienced technical problems, such as crashing or errors, while using the app. 3. Limited scope: Users noted that the app only screens for depression and does not address other mental health conditions. Please note that these conclusions are based on the available user reviews at the time of my analysis, which may change over time.
App Downloads
IOS
App Survey
  • Whether the application ad recommendation affects the experience?
      Submission Failed, try again
  • How much time do you spend on app applications every day?
      Submission Failed, try again
  • Do you think the aesthetics of the interface UI affects the experience?
      Submission Failed, try again
  • The degree of memory and power consumption Does it affect the experience?
      Submission Failed, try again
Description
The Patient Health Questionnaire (PHQ) is a multiple-choice self-report inventory copyrighted by Pfizer Inc, that is used as a screening and diagnostic tool for mental health disorders of depression, anxiety, alcohol, eating, and somatoform. It is the self-report version of the Primary Care Evaluation of Mental Disorders (PRIME-MD), a diagnostic tool developed in the mid-1990s by Pfizer Inc.
{{descriptionMoreText}}
Comments (0)
{{commentText.length}}/{{maxCommentText}}
{{commentError}}{{commentUserError}}
Failed to load data, try again
  • {{comment.commentUser.substring(0, 1)}}
    By {{comment.commentUser}}{{comment.commentDateString}}
    {{comment.comment}}